Compare CNTB & NNBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTB | NNBR |
|---|---|---|
| Founded | 2012 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.7M | 162.5M |
| IPO Year | 2020 | 1996 |
| Metric | CNTB | NNBR |
|---|---|---|
| Price | $2.21 | $3.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $8.67 | $3.00 |
| AVG Volume (30 Days) | 677.5K | ★ 4.9M |
| Earning Date | 08-13-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.60 |
| EPS | N/A | ★ N/A |
| Revenue | $64,000.00 | ★ $770,657,000.00 |
| Revenue This Year | N/A | $8.60 |
| Revenue Next Year | N/A | $6.30 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.23 | $1.10 |
| 52 Week High | $3.82 | $4.44 |
| Indicator | CNTB | NNBR |
|---|---|---|
| Relative Strength Index (RSI) | 46.82 | 54.40 |
| Support Level | $2.14 | $1.31 |
| Resistance Level | $2.75 | $4.44 |
| Average True Range (ATR) | 0.23 | 0.36 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 10.87 | 31.46 |
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
NN Inc is a diversified industrial company that combines engineering and production capabilities with materials science expertise to design and manufacture high-precision components and solutions. The company operates through two segments: Mobile Solutions, which generates maximum revenue and focuses on the automotive, general industrial, and medical end markets, manufacturing tight-tolerance components used in battery electric, hybrid electric, and internal combustion engine vehicles, braking, transmissions, fuel systems, HVAC, and diesel systems; and Power Solutions, which focuses on the electrical, general industrial, automotive, medical, and aerospace and defense end markets and manufactures high-precision metal components, assemblies, contact assemblies, and precision stampings.